The private biopharmaceutical company, Aculys Pharma, is launching a phase III therapeutic trial for excessive daytime sleepiness (EDS). The test patients in this trial have obstructive sleep apnea syndrome (OSA) and complain of EDS. This is manifested by upper airway obstruction, coupled with fatigue, drowsiness and...
On March 24, 2023, the Regional Day of Allergology News will take place, organised by Pathologie Thoracique du Nord. See you in Lille-Sequin....
Bioprojet has been nominated for the 4th time by Prescrire in the Palmarès de l'Information for the quality of the information provided during the year 2022! It is a real honour to receive this positive distinction for the fourth consecutive year....
Bioprojet has just signed an exclusive licence contract with Acino, the Zurich-based Swiss pharmaceutical distributor, for the registration, marketing and distribution of pitolisant in Saudi Arabia with possible extension to other Middle Eastern countries....